Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yuki Tahata
NS5A-P32 Deletion After Failure of Ledipasvir/Sofosbuvir in Hepatitis C Virus Genotype 1b Infection
Hepatology
Medicine
Hepatology
Related publications
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy
Gastroenterology
Hepatology
Gastroenterology
Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure
Hepatology
Medicine
Hepatology
Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants During SOF/LDV Combination Therapy Against Genotype 1b Hepatitis C Virus (HCV)
Scientific Reports
Multidisciplinary
Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ledipasvir and Sofosbuvir for Recurrent Hepatitis C After Liver Transplantation
BioScience Trends
Biochemistry
Health
Medicine
Genetics
Molecular Biology
Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population
Digestive Diseases and Sciences
Physiology
Gastroenterology
Effectiveness of Elbasvir/Grazoprevir in US Veterans With Chronic Hepatitis C Virus Genotype 1b Infection
Infectious Diseases and Therapy
Infectious Diseases
Microbiology
Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in Treatment-Naïve Hepatitis C Virus Genotype 1-Infected Patients Without Cirrhosis Treated With a Simeprevir/Sofosbuvir/Ledipasvir Regimen
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Treatment Efficacy of All-Oral Combinations of Direct-Acting Antivirals in Chronic Hepatitis C Patients With NS5A-P32 Deletion
Acta Hepatologica Japonica
Hepatology
